Skip to main content

NVS Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Novartis AG News

Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact

Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.

Novartis and Roche Have Expensive Drugs That Scare Away Competitors

A brief snapshot of some medical breakthroughs that are among the costliest in the world.

5 Top Stock Gainers for Thursday Amid Central Bank Policy Calls

Stocks were mixed Thursday as investors digested policy decisions made by the U.S. Federal Reserve and the Bank of England.

Emergent BioSolutions Begins Phase 1 Trial for Universal Flu Vaccine

Emergent says its flu-vaccine candidate 'contains multiple components to induce broad, supra-seasonal immunity against influenza A viruses.'

Buyback Bonanza: Novartis May Snap Up $15 Billion of Stock

Swiss drug giant Novartis NVS said it plans to deploy up to $15 billion for share buybacks, thanks to its $21 billion sale of Roche shares.

Breaking News

Costco May Have a Huge Workers Problem

Workers demand for their needs to be met.

Real Estate Titan Zillow Sees Tough Times Ahead in Housing

The residential real estate market has stumbled, after soaring in the first 18 months of the covid pandemic.

Meta (Facebook) Looks to Take on TikTok Next

Facebook and Instagram's parent company has a plan to take over a new segment.